Main content area

Akt1 governs breast cancer progression in vivo

Ju, Xiaoming, Katiyar, Sanjay, Wang, Chenguang, Liu, Manran, Jiao, Xuanmao, Li, Shengwen, Zhou, Jie, Turner, Jacob, Lisanti, Michael P., Russell, Robert G., Mueller, Susette C., Ojeifo, John, Chen, William S., Hay, Nissim, Pestell, Richard G.
Proceedings of the National Academy of Sciences of the United States of America 2007 v.104 no.18 pp. 7438-7443
breast neoplasms, carcinogenesis, chemokine CXCL16, cyclins, endothelial cells, genes, metabolism, metastasis, mice, migratory behavior, neoplasm cells, paracrine signaling, phosphorylation, proteomics, sclerosis, secretion, serine, threonine
The serine threonine kinase Akt1 has been implicated in the control of cellular metabolism, survival and growth. Here, disruption of the ubiquitously expressed member of the Akt family of genes, Akt1, in the mouse demonstrates a requirement for Akt1 in ErbB2-induced mammary tumorigenesis. Akt1 deficiency delayed tumor growth and reduced lung metastases, correlating with a reduction in phosphorylation of the Akt1 target, tuberous sclerosis 2 (TSC2) at Ser-939. Akt1-deficient mammary epithelial tumor cells (MEC) were reduced in size and proliferative capacity, with reduced cyclin D1 and p27KIP¹ abundance. Akt1 deficiency abrogated the oncogene-induced changes in polarization of MEC in three-dimensional culture and reverted oncogene-induced relocalization of the phosphorylated ezrin-radixin-moesin proteins. Akt1 increased MEC migration across an endothelial cell barrier, enhancing the persistence of migratory directionality. An unbiased proteomic analysis demonstrated Akt1 mediated MEC migration through paracrine signaling via induction of expression and secretion of CXCL16 and MIP1γ. Akt1 governs MEC polarity, migratory directionality and breast cancer onset induced by ErbB2 in vivo.